|
2025
|
Invention
|
Human papillomavirus vaccines and uses of the same.
Provided herein are engineered human papillo... |
|
|
Invention
|
Ror-1 specific chimeric antigen receptors and uses thereof.
Provided herein are chimeric antigen... |
|
|
Invention
|
Hepatitis b vaccines and uses of the same.
Provided herein are engineered hepatitis B virus (HBV... |
|
2024
|
Invention
|
Fusion constructs and methods of using thereof.
A fusion protein comprising: a first component c... |
|
|
Invention
|
Expression of novel cell tags.
Disclosed herein are polynucleotides encoding cell tags for use i... |
|
|
P/S
|
Promoting public awareness of issues and risks relating to recurrent respiratory papillomatosis a... |
|
|
P/S
|
Promoting public awareness of issues and risks relating to
recurrent respiratory papillomatosis ... |
|
|
Invention
|
Cd19-targeted car t cell therapy |
|
|
Invention
|
Cd19-targeted car t cell therapy. A chimeric antigen receptor (CAR), for example a CD19-specific ... |
|
|
Invention
|
Therapy for alpha-1 antitrypsin deficiency. iiyamamaltonmalton). The construct may further compri... |
|
|
Invention
|
Therapy for alpha-1 antitrypsin deficiency |
|
|
P/S
|
Vaccines for humans; therapeutic vaccines for humans; therapeutic vaccines for the treatment of H... |
|
|
P/S
|
Vaccines; therapeutic vaccines; therapeutic vaccines for the
treatment of Human Papilloma Virus ... |
|
|
Invention
|
Novel adenovirus vaccine therapy for the treatment of recurrent respiratory papillomatosis.
Mult... |
|
|
Invention
|
Human papillomavirus vaccines and uses of the same |
|
|
Invention
|
Novel adenovirus vaccine therapy for the treatment of recurrent respiratory papillomatosis |
|
|
Invention
|
Human papillomavirus vaccines and uses of the same.
Multi-antigenic human papilloma virus (HPV) ... |
|
|
Invention
|
Human papillomavirus vaccines and uses of the same. Multi-antigenic human papilloma virus (HPV) m... |
|
|
Invention
|
Novel adenovirus vaccine therapy for the treatment of recurrent respiratory papillomatosis. Multi... |
|
|
Invention
|
T cell receptors generated as a result of hpv vaccine therapy and methods of treating patients wi... |
|
|
Invention
|
Muc16 specific chimeric antigen receptors and uses thereof.
Provided herein are chimeric antigen... |
|
|
Invention
|
Modulating expression of polypeptides via new gene switch expression systems.
Disclosed herein a... |
|
2023
|
P/S
|
Vaccines; therapeutic vaccines; therapeutic vaccines for the treatment of Human Papilloma Virus (... |
|
|
Invention
|
Compositions and methods for expression of multiple biologically active polypeptides from a singl... |
|
|
Invention
|
Cd33 specific chimeric antigen receptors. Provided herein are chimeric antigen receptors (CARs) f... |
|
|
P/S
|
Scientific and technological services and biological research and development relating thereto, n... |
|
|
Invention
|
Frataxin expression constructs.
The invention provides polynucleotides, vectors and viruses expr... |
|
|
Invention
|
Polycistronic mirna constructs for immune checkpoint inhibition.
A ribonucleic acid comprising t... |
|
|
Invention
|
Polycistronic mirna constructs for immune checkpoint inhibition |
|
|
Invention
|
Polycistronic mirna constructs for immune checkpoint inhibition. A ribonucleic acid comprising tw... |
|
|
Invention
|
Polypeptide compositions comprising spacers.
Disclosed herein are methods and compositions inclu... |
|
|
P/S
|
Chemicals, biochemicals and reagents for use in industry and science; chemicals, biochemicals and... |
|
|
P/S
|
Scientific research and development services in the field of medicine, pharmacology, immunology, ... |
|
2022
|
Invention
|
Hepatitis b vaccines and uses of the same. Provided herein are engineered hepatitis B virus (HBV)... |
|
|
Invention
|
Fusion constructs and methods of using thereof.
Provided herein is a composition comprising a fu... |
|
|
Invention
|
Buffer solutions for electroporation.
An electroporation buffer comprising: a solvent; a sugar; ... |
|
|
Invention
|
Buffer solutions for electroporation. An electroporation buffer comprising: a solvent; a sugar; a... |
|
|
Invention
|
Buffer solutions for electroporation. 22); and the buffering agent is sodium phosphate, 4-(2-hydr... |
|
|
Invention
|
Muc16 specific chimeric antigen receptors and uses thereof. Provided herein are chimeric antigen ... |
|
|
Invention
|
Chimeric receptor therapy. A non-naturally occurring polynucleotide encoding a miRNA that inhibit... |
|
|
Invention
|
Chimeric receptor therapy.
A non-naturally occurring polynucleotide encoding a miRNA that inhibi... |
|
2021
|
Invention
|
Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof.
Pr... |
|
|
Invention
|
Human papilloma virus vaccines and uses of the same for hpv associated diseases.
Provided herein... |
|
|
Invention
|
Human papilloma virus vaccines and uses of the same for hpv associated diseases. Provided herein ... |
|
|
Invention
|
Fusion constructs and methods of using thereof. A fusion protein comprising: a first component co... |
|
|
Invention
|
Expression of novel cell tags. Disclosed herein are polynucleotides encoding cell tags for use in... |
|
|
Invention
|
Ror-1 specific chimeric antigen receptors and uses thereof. Provided herein are chimeric antigen ... |
|
2020
|
Invention
|
Frataxin expression constructs. The invention provides polynucleotides, vectors and viruses expre... |
|
|
Invention
|
Electroporation apparatus and method. Electroporation is a technique in which an electrical field... |
|
2019
|
P/S
|
Laboratory apparatus for introduction of nucleic acids into cells by transient application of ele... |
|
|
Invention
|
In vivo controlled combination therapy for treatment of cancer.
Disclosed herein are improved me... |
|
2017
|
P/S
|
Chemicals, biochemicals and reagents for use in industry and science, namely, scientific research... |
|
2011
|
P/S
|
Providing technology for the design and development of biological components; Providing informati... |
|
|
P/S
|
Development of new technology for others in the field of biotechnology; Providing information in ... |
|
2008
|
P/S
|
Medical services |
|
2007
|
P/S
|
Development of new technology for others in the field of genetics and biotechnology |
|
2005
|
P/S
|
Research and development services for others in the fields of genetics and biotechnology, namely,... |
